What matters most is having ongoing support to help them succeed with whichever approach makes sense for them." This is where clinical judgment matters
Success with GLP-1 medications comes after sustained use
positions it to compete in the evolving obesity treatment market with innovative GLP-1 therapies
FDA approval estimated late 2027mid-2028
Your provider should: Evaluate your medical history and current health status Order baseline lab work (IGF-1, metabolic panel, hormones) Determine an appropriate starting dose Monitor your progress with follow-up labs and consultations Adjust your protocol based on your response Be proactive in communicating with your provider about your response, any side effects, and your treatment goals
To support this Website, Podcast, and all of our other health fitness educational media content, Haywood Doe Consulting Co